# clm_CFD74D844717

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_assets  
value: 40,558,700,000 United States dollar  
valid_from: 2025-12-31  
valid_to: 2026-03-31  
published: 2026-02-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_81C2322B5ECE  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total assets: 40,558,700,000 United States dollar", as of 2025-12-31 (until 2026-03-31). Claim clm_CFD74D844717, https://asof.is/claim/clm_CFD74D844717, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Assets in 10-K FY2025, filed 2026-02-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm (primary, SEC EDGAR 10-K FY2025, published 2026-02-04)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 40,169,400,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_CFD74D844717](/claim/clm_CFD74D844717.md) | [clm_A47C41C5A48C](/claim/clm_A47C41C5A48C.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.